Garg Vipin K.'s most recent trade in Altimmune Inc was a trade of 26,775 Restricted Stock Units done . Disclosure was reported to the exchange on Jan. 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Jan 2025 | 26,775 | 53,550 | - | - | Restricted Stock Units | ||
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Jan 2025 | 26,775 | 342,696 (2%) | 0% | 0 | Common Stock, par value $0.0001 | ||
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Jan 2025 | 18,950 | 18,950 | - | - | Restricted Stock Units | ||
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Jan 2025 | 18,950 | 363,364 (2%) | 0% | 0 | Common Stock, par value $0.0001 | ||
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Jan 2025 | 16,545 | 0 | - | - | Restricted Stock Units | ||
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Jan 2025 | 16,545 | 351,645 (2%) | 0% | 0 | Common Stock, par value $0.0001 | ||
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Jan 2025 | 11,701 | 330,995 (2%) | 0% | 7 | 81,907 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Jan 2025 | 8,282 | 355,082 (2%) | 0% | 6.6 | 54,992 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Jan 2025 | 7,231 | 344,414 (2%) | 0% | 6.6 | 48,014 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Jan 2025 | 4,105 | 335,100 (2%) | 0% | 5.2 | 21,264 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 25 Jan 2025 | 477,500 | 477,500 | - | - | Stock Options (option to buy) | ||
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 25 Jan 2025 | 164,800 | 164,800 | - | - | Restricted Stock Units | ||
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 25 Jan 2025 | 42,050 | 334,078 (2%) | 0% | 0 | Common Stock, par value $0.0001 | ||
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 25 Jan 2025 | 42,050 | 126,150 | - | - | Restricted Stock Units | ||
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 25 Jan 2025 | 18,157 | 315,921 (2%) | 0% | 7.0 | 126,736 | Common Stock, par value $0.0001 | |
| Altimmune Inc | K. Vipin Garg | Director, President and CEO | 01 Feb 2024 | 18,950 | 300,404 (1%) | 0% | 0 | Common Stock, par value $0.0001 | ||
| Altimmune Inc | K. Garg Vipin | Director, President and CEO | 01 Feb 2024 | 18,950 | 37,900 | - | - | Restricted Stock Units | ||
| Altimmune Inc | Garg Vipin K. | Director, President and CEO | 01 Feb 2024 | 16,545 | 288,767 (1%) | 0% | 0 | Common Stock, par value $0.0001 | ||
| Altimmune Inc | Garg Vipin K. | Director, President and CEO | 01 Feb 2024 | 16,545 | 16,545 | - | - | Restricted Stock Units | ||
| Altimmune Inc | K. Garg Vipin | Director, President and CEO | 01 Feb 2024 | 8,376 | 292,028 (1%) | 0% | 9.3 | 78,064 | Common Stock, par value $0.0001 | |
| Altimmune Inc | K. Garg Vipin | Director, President and CEO | 01 Feb 2024 | 7,313 | 281,454 (1%) | 0% | 9.9 | 72,252 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Garg K. Vipin | Director, President and CEO | 30 Jan 2024 | 26,775 | 80,325 | - | - | Restricted Stock Units | ||
| Altimmune Inc | K. Garg Vipin | Director, President and CEO | 30 Jan 2024 | 26,775 | 276,030 (1%) | 0% | 0 | Common Stock, par value $0.0001 | ||
| Altimmune Inc | Vipin Garg K. | Director, President and CEO | 30 Jan 2024 | 11,697 | 264,333 (1%) | 0% | 9.8 | 114,631 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Garg Vipin K. | Director, President and CEO | 30 Jan 2024 | 7,889 | 272,222 (1%) | 0% | 2.7 | 21,221 | Common Stock, par value $0.0001 | |
| Altimmune Inc | K. Vipin Garg | Director, President and CEO | 25 Jan 2024 | 470,000 | 470,000 | - | - | Stock Options (option to buy) | ||
| Altimmune Inc | Garg K. Vipin | Director, President and CEO | 25 Jan 2024 | 168,200 | 168,200 | - | - | Restricted Stock Units | ||
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 31 Jul 2023 | 126 | 249,255 (1%) | 0% | 2.8 | 354 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 02 Feb 2023 | 18,950 | 257,551 (1%) | 0% | 0 | Common Stock, par value $0.0001 | ||
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 02 Feb 2023 | 18,950 | 56,850 | - | - | Restricted Stock Units | ||
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 02 Feb 2023 | 8,422 | 249,129 (1%) | 0% | 15.0 | 126,667 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 31 Jan 2023 | 16,546 | 33,090 | - | - | Restricted Stock Units | ||
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 31 Jan 2023 | 16,546 | 246,259 (1%) | 0% | 0 | Common Stock, par value $0.0001 | ||
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 31 Jan 2023 | 7,658 | 238,601 (1%) | 0% | 13.8 | 105,527 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 31 Jan 2023 | 1,938 | 229,713 (1%) | 0% | 10.2 | 19,784 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Jan 2023 | 302,900 | 302,900 | - | - | Stock Options (option to buy) | ||
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Jan 2023 | 107,100 | 107,100 | - | - | Restricted Stock Units | ||
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Nov 2022 | 3,007 | 227,775 (1%) | 0% | 10.0 | 29,920 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Oct 2022 | 3,007 | 230,782 (1%) | 0% | 12.8 | 38,399 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Sep 2022 | 3,008 | 233,789 (1%) | 0% | 12.8 | 38,412 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Aug 2022 | 20,000 | 236,797 (1%) | 0% | 20.0 | 400,322 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Aug 2022 | 3,007 | 256,797 (1%) | 0% | 18.9 | 56,953 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Jul 2022 | 3,007 | 274,804 (1%) | 0% | 12.0 | 36,114 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Jun 2022 | 3,007 | 277,811 (1%) | 0% | 11.7 | 35,182 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 May 2022 | 3,008 | 280,818 (1%) | 0% | 5.0 | 15,130 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Apr 2022 | 3,008 | 283,826 (1%) | 0% | 4.5 | 13,596 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Mar 2022 | 3,007 | 286,834 (1%) | 0% | 6.0 | 18,192 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 28 Feb 2022 | 3,007 | 289,841 (1%) | 0% | 7.4 | 22,282 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 31 Jan 2022 | 223,000 | 223,000 | - | - | Stock Options (option to buy) | ||
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 31 Jan 2022 | 75,800 | 75,800 | - | - | Restricted Stock Units | ||
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 31 Jan 2022 | 16,545 | 300,503 (1%) | 0% | 0 | Common Stock, par value $0.0001 | ||
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 31 Jan 2022 | 16,545 | 49,636 | - | - | Restricted Stock Units | ||
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 31 Jan 2022 | 7,655 | 292,848 (1%) | 0% | 8.0 | 61,087 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 31 Jan 2022 | 2,757 | 283,958 (1%) | 0% | 6.9 | 18,913 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Jan 2022 | 2,355 | 281,201 (1%) | 0% | 7.2 | 16,956 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Nov 2021 | 3,007 | 286,563 (1%) | 0% | 10.5 | 31,543 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Oct 2021 | 3,007 | 289,570 (1%) | 0% | 10.8 | 32,476 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Sep 2021 | 3,007 | 292,577 (1%) | 0% | 11.3 | 34,009 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Aug 2021 | 3,008 | 295,584 (1%) | 0% | 14.1 | 42,383 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Jul 2021 | 3,007 | 298,592 (1%) | 0% | 9.1 | 27,273 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Jun 2021 | 3,007 | 301,599 (1%) | 0% | 9.9 | 29,619 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 May 2021 | 2,577 | 304,606 (1%) | 0% | 12.6 | 32,599 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Apr 2021 | 1,999 | 307,183 (2%) | 0% | 14.5 | 28,926 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Mar 2021 | 1,998 | 309,182 (2%) | 0% | 13.6 | 27,073 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 28 Feb 2021 | 1,998 | 311,180 (2%) | 0% | 15.9 | 31,848 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 31 Jan 2021 | 241,500 | 241,500 | - | - | Stock Options (option to buy) | ||
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 31 Jan 2021 | 66,181 | 66,181 | - | - | Restricted Stock Units | ||
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 31 Jan 2021 | 1,055 | 313,178 (2%) | 0% | 12.1 | 12,808 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Vipin K. Garg | Director, President and CEO | 30 Jan 2021 | 2,353 | 312,123 (2%) | 0% | 14.3 | 33,601 | Common Stock, par value $0.0001 |